The Clinical Evaluation Report (CER) Requirements under the EU MDR 2017/745

Actions Panel

Early access

The Clinical Evaluation Report (CER) Requirements under the EU MDR 2017/745

The Clinical Evaluation Requirements (CER) under the EU MDR 2017/745; June 19-20, 2023; 2 half-days training

By GMED North America, Inc.

When and where

Date and time

Starts on Monday, June 19 · 7am PDT



Refund Policy

Contact the organizer to request a refund.
Eventbrite's fee is nonrefundable.

About this event

  • 1 day 4 hours
  • Mobile eTicket

About the training

Training Time: 2 half-day sessions: June 19, 10am - 2pm; June 20, 10am - 2pm

All medical devices sold into Europe, new or existing, and irrespective of specification, must have an up-to-date Clinical Evaluation Report (CER) as part of its Technical File. However, despite the CER being a critical compliance element for medical device manufacturers doing business in the EU, there continues to be a significant lack of clarity regarding key requirements and best practices for creating these reports. Without a clear understanding of what is required, both manufacturers and Notified Bodies (NBs) struggle to apply a consistent approach to the CER process.

Now that the new Medical Device Regulation (EU) 2017/745 has come into force in the European Union, there is an even greater emphasis on providing supporting clinical data, combined with the need to suitably plan CERs and fully document the approach and processes around it.

To seamlessly manage the CER process so that clinical data is regularly updated without causing major bottlenecks, or stalling, in productivity, it is critical that medical device manufacturers establish now a clear strategy towards their Clinical Evaluation Reports (CERs).


  • Good knowledge and effective practice of the Directives 93/42/EEC or/and 90/385/EEC.

Who Should Attend

  • Medical Device Manufacturers
  • Internal and external Auditors
  • Regulatory Affairs Managers and Quality Managers
  • R&D specialists
  • Development, Manufacturing and Marketing Managers

Learning Objectives

  • Identify the key changes for Clinical data under the Regulation (EU) 2017/745 (MDR)
  • Determine what is considered “sufficient” clinical data for clinical evaluations
  • Understand the Clinical Investigation Requirements
  • Identify the Post-Market Surveillance Requirements (PMS), the Post-Market Clinical Follow-Up (PMCF), and the Periodic Safety Update Report (PSUR)

Educational Resources

  • Presentations
  • Practical working sessions
  • Course evaluation


  • Changes for definitions between MDR and MDD
  • Equivalence
  • Appraisal of clinical data
  • Analysis of clinical data
  • Post-market surveillance requirements, including PMCF and PSUR
  • Unique Device Identifier and Eudamed
  • Summary of safety and clinical performance (Article 32)
  • Expert panel consultation (Articles 61 section 2)
  • Practical working sessions
  • Group workshop
  • Course Evaluation
  • Summary and Discussion with the trainer

About the Trainer

Christopher Brodrick

Design Dossier Evaluator

Christopher Brodrick is a Design Dossier Evaluator at GMED NA specializing in Cardiovascular and Neurovascular devices. He has a Master’s Degree in Biomedical Engineering from the University of Virginia, as well as a Bachelor’s Degree in Materials Engineering from Virginia Tech. His past roles have included Clinical Affairs Manager at another notified body, Senior Consultant within a large CE Mark consulting company, and he has worked in the cardiovascular device industry as a R&D Engineer. He has broad expertise in the area of Clinical Evaluation for CE Marking and is a frequent speaker and trainer on this topic.

About the organizer

 GMED North America. is the subsidiary of GMED, leading Certification Organization & distinguished Notified Body (CE0459).

GMED is a leading Certification Organization and a distinguished Notified Body (CE0459) whose scope covers all of the existing European Medical Device Directives (90/385/EEC, 93/42/EEC and 98/79/EC).


GMED is also an Auditing Organization Recognized by the MDSAP Regulatory Authority Council and has been performing MDSAP audits since April 2015. GMED is accredited under the NF EN IEC/ISO 17021-1:2015 standard by COFRAC (Certificate № 4-0608), the French Accreditation Committee, to carry out Quality Management System Certification activities according to ISO 9001:2015 and ISO 13485:2016. 


Established in 1994, GMED is fully owned by LNE (e.1901), a State owned Industrial and Commercial Establishment (EPIC), and operates since August 1st, 2018 as a simplified joint stock company (SAS) within the LNE group. 


GMED’s success and high level of performance rely first and foremost on a strong and dedicated team of individuals trained at the highest level of the current evaluation and auditing methods to provide the best certification services: Certification Project Managers, Subject Matters Specialists (MDAO or Medical Device Animal Origin, Medicinal Substance, Active Implantable Medical Devices, Microbiologists), Technical Documentation Evaluators and Design Dossier Assessors, Clinical Reviewers & Experts (Ex: Sterilization Methods and Validation) and Auditors for CE marking and QMS activities. 


With offices in Europe and a dedicated US Operation created in 2005 - GMED North America (MD), GMED offers the convenience and efficiency of local teams of experimented specialists to accompany your certification process which will allow you to market in your target markets.